Table 2.
Results of meta-analysis.
| Study | ES | 95% CI | Weight (%) |
|---|---|---|---|
| Postoperative/in-hospital complications | |||
| Kua (16) | 3.42 | (1.09, 10.75) | 4.75 |
| Chan (17) | 4.80 | (2.10, 10.80) | 8.48 |
| Choi (20) | 1.24 | (1.12, 1.38) | 44.38 |
| Choi (22) | 1.25 | (1.09, 1.43) | 42.39 |
| Total (95% CI) I2 = 63.3%, (p <0.0001) | 1.46 | (1.13, 1.90) | 100.00 |
| In-patient mortality | |||
| Shimizu (24) | 1.57 | (1.12, 2.21) | 73.73 |
| Thorne (23) | 2.03 | (1.15, 3.58) | 26.27 |
| Total (95% CI) I2 = 0.0%, (p <0.0001) | 1.68 | (1.26, 2.25) | 100.00 |
| 6-month mortality | |||
| Kua (16) | 1.95 | (0.19, 20.28) | 0.46 |
| Chen (18) | 4.60 | (1.05, 20.04) | 1.16 |
| Choi (22) | 1.40 | (1.03, 1.92) | 25.95 |
| Choi (20) | 1.46 | (1.21, 1.76) | 72.43 |
| Total (95% CI) I2 = 0.0%, (p <0.0001) | 1.46 | (1.25, 1.72) | 100.00 |
| ≥1-year mortality | |||
| Patel (15) | 4.97 | (3.06, 8.09) | 12.47 |
| Pizzonia (6) | 5.63 | (2.31, 13.75) | 7.09 |
| Winter (19) | 3.50 | (2.10, 5.70) | 12.25 |
| Jorissen (21) | 1.25 | (1.11, 1.41) | 17.84 |
| Thorne (23) | 2.87 | (2.10, 3.92) | 15.36 |
| Choi (20) | 1.42 | (1.24, 1.63) | 17.69 |
| Choi (22) | 1.49 | (1.25, 1.77) | 17.30 |
| Total (95% CI) I2 = 91.3%, (p <0.0001) | 2.24 | (1.66, 3.04) | 100.00 |
| Adverse discharge destination | |||
| Thorne (23) | 0.8 | (0.46, 1.39) | 54.40 |
| Chan (17) | 23.00 | (3.00, 173.50) | 45.60 |
| Total (95% CI) I2 = 89.8%, (p > 0.05) | 3.70 | (0.14, 98.22) | 100.00 |
| Prolonged hospital stays | |||
| Choi (20) | 1.19 | (1.05, 1.34) | 80.82 |
| Thorne (23) | 1.02 | (0.80, 1.31) | 19.18 |
| Total (95% CI) I2 = 14.8%, (P = 0.01) | 1.15 | (1.03, 1.28) | 100.00 |